יום חמישי, כ״ד תמוז תשפ״וThursday, July 9, 2026
Follow Us
CEO Kåre Schultz his restructuring plan would restore the company’s financial security and stabilize its business.
The strike announcement followed reports that the company will announce as many as 3200 layoffs tomorrow.
The major indices on the Tel Aviv Stock Exchange (TASE) traded almost unchanged Tuesday with the TA-35 moving 0.03 percent and the TA-125 edging up 0.21 percent.
By JNi.Media
This collapse comes in the wake of the world's biggest generic drugs maker attempt to dominate its market with a $40.5 billion acquisition of Allergan's generics business last year. It was a bad call.
By JNi.Media
It comes down to control: the most outstanding feature of the new inhaler is that it delivers precise doses, allowing physicians to monitor and curtail their patients' cannabis consumption.
An Israeli executive claims an Avis agent said it was "company policy not to recognize Israeli documents."
By JNi.Media
This appears to be a strategic switch away from Mylan, which was fighting the Teva takeover.
Israel's giant generic firm will withdraw its troublesome bid for Mylan.
Pres. Reuven Rivlin launches joint project with 'Collective Impact' to integrate Israeli Arab workers into private business sector.
The Israeli economy is on the way to becoming owned by foreigners.
By Anav Silverman, Tazpit News Agency
Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.
The U.S. Food and Drug Administration (FDA) has granted Israeli-based Teva Pharmaceuticals full approval for Synribo, a drug that is injected for adults with a with chronic phase or accelerated phase of myeloid leukemia. Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is one of four main types of leukemia and is a cancer […]
Teva Pharmaceutical announced on Thursday that its new CEO will be Erez Vigodman, who until now has been the CEO for the huge phosphate and chemical producer Makhteshim Agan Industries. Vigodman replaces Dr. Jeremy Levin, who moved to Israel two years to take over the world’s largest generic drug company, which has been faltering since […]
Jeremy Levin, who moved to Israel last year to take over the helm at Teva Pharmaceuticals only to be fired last month, say he loves Israel and is staying here, at least for the time being. Unlike Stanley Fischer, who made aliya to take over the post of Governor of the Bank of Israel and […]
Israel’s giant generic Teva Pharmaceuticals firm will fire by the end of next year 5,000 employees around the world, including hundreds in Israel, as one of the “steps to accelerate the reduction of costs and to optimize its structure.” Most of the layoffs will be outside Israel, said Teva CEO Jeremy Levin, who moved to […]
Kitov Pharmaceuticals accounted it plans to apply for listing on the NASDAQ exchange, joining Israel-based Teva and Kamada that are traded on Wall Street. Kitov is hoping for approval from the U.S. Food and Drug Administration (FDA) after its Phase III clinical trial of a combination drug for the treatment of hypertension and pain relief. […]
The pharmaceutical giant Teva's French division, Teva France, announced that the preliminary investigation conducted by the Paris Prosecutor resulted in the conclusion that there were no signs of Zopiclone in Furosemide tablets manufactured by Teva. Therefore, the prosecutor decided that there is no connection between the Teva plant in Sens, France, where the drug Furosemide […]
Teva, the world leader in generic medication will be soon be launching a generic version of Pfizer's Viagra in the UK and Europe. Pfizer's Viagra patents expired this past week in the UK and parts of Europe, allowing other manufacturers to move in. In the US, a court ruling has prevented Teva from introducing generic […]
July 3, 2026 
